Journal of International Psychiatry

Objective To explore the clinical application value of ozagrel sodium combined dailixin in the treat-ment of post-cerebral infarction anxiety and depression. Methods 90 cases of cerebral infarction patients in our hospitalfrom April 2013 to August 2014 were divided into experimental and control groups. Control group was given ozagrel so-dium treatment，theexperimental groupwasgivenozagrel sodium+Dailixin，after3monthsof treatment，theanxiety ，theexperimental groupwasgivenozagrel sodium+Dailixin，after3monthsof treatment，theanxiety the experimental group was given ozagrel sodium + Dailixin，after3monthsof treatment，theanxiety ，after3monthsof treatment，theanxiety after 3 months of treatment，theanxiety ，theanxiety the anxietyand depression improvement situation，abilityof dailyliving，nervefunctionandprognosiswereobservedandcom- ，abilityof dailyliving，nervefunctionandprognosiswereobservedandcom- ability of daily living，nervefunctionandprognosiswereobservedandcom- ，nervefunctionandprognosiswereobservedandcom- nerve function and prognosis were observed and com-pared. Results Before the intervention，thetwogroupsofpatientsSelf-RatingAnxietyScale（SAS）andtheSelf-Rat- ，thetwogroupsofpatientsSelf-RatingAnxietyScale（SAS）andtheSelf-Rat- the two groups of patients Self-Rating Anxiety Scale（SAS）andtheSelf-Rat- （SAS）andtheSelf-Rat- SAS）andtheSelf-Rat- ）andtheSelf-Rat- and the Self-Rat-ing Depression Scale（SDS）scoreswerenotsignificantlydifferent（ （SDS）scoreswerenotsignificantlydifferent（ SDS）scoreswerenotsignificantlydifferent（ ）scoreswerenotsignificantlydifferent（ scores were not significantly different（P >0.05），aftertreatment，theSASandSDSscores ），aftertreatment，theSASandSDSscores after treatment，theSASandSDSscores ，theSASandSDSscores the SAS and SDS scoresof experimental group were significantly lower than the control group（P <0.01）. Theexperimental groupandcontrol ）. Theexperimental groupandcontrol . The experimental group and controlgroup total effective rate were 91.11％，73.33％，thedifferencewasstatisticallysignificant（ ％，73.33％，thedifferencewasstatisticallysignificant（ 73.33％，thedifferencewasstatisticallysignificant（ ％，thedifferencewasstatisticallysignificant（ the difference was statistically significant（P <0.01）. ）. Conclusion The ozagrel sodium combined dailixin intervention of anxiety and depression in patients with cerebral infarction has goodtreatment effect，andisworthyofclinicalpopularizationandapplication. ，andisworthyofclinicalpopularizationandapplication. and is worthy of clinical popularization and application.

Ozagrel sodium；Dailixin；Cerebralinfarction；Anxiety；Depression